Journal Information
Articles in press
Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
Protocol for the adaptation and consensus of the Community Pharmacy Survey on Patient Safety Culture to hospital pharmacy in Spain
Juan Manuel Rodríguez-Camacho, José Manuel Caro-Teller, Sergio Plata-Paniagua, Juan Alfredo Montero-Delgado, Inés Jiménez-Lozano, Carmen María Cuadros-Martínez
10.1016/j.farma.2024.12.008
Full text access
Available online 23 January 2025
Prospective observational follow-up study of psychoactive drug treatment initiated in the intensive care unit
Laura Doménech-Moral, Javier Santader-Reboreda, Meri Martin-Cerezuela, Amaia Egüés Lugea, Marcos Buj Vicente, Sofía Contreras Medina
10.1016/j.farma.2024.12.003
Full text access
Available online 22 January 2025
High-risk pediatric medications: A listing proposal by interdisciplinary consensus technique
Yolanda Hernández Gago, Pedro Alcalá Minagorre, Belén Rodríguez Marrodán, Laura Hernández Sabater, María José Cabañas Poy, Cristina Martínez Roca, Jimena Pérez Moreno
10.1016/j.farma.2024.11.006
Full text access
Available online 3 January 2025
Drug dosing in obese critically ill patients, a literature review
Hector Carlos García-Díaz, Pablo Sánchez-Sancho, Pilar Lalueza-Broto, Xavier Nuvials, María Queralt Gorgas Torner, Laura Doménech Moral
10.1016/j.farma.2024.11.008
Full text access
Available online 30 December 2024
National survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life-support techniques: The DOSEBL study protocol
Alba Pau-Parra, María Núñez-Núñez, Svetlana Sadyrbaeva Dolgova, Laura Doménech Moral, Eva Campelo Sánchez, Leonor del Mar Periañez Parraga, Khalid Saeed Khan, Sònia Luque Pardos
10.1016/j.farma.2024.11.005
Full text access
Available online 16 December 2024
Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain
Fernando Pérez-Ruiz, Carlos Crespo-Diz, Joan Antoni Schoenenberger-Arnaiz, Mónica Cerezales, Marcelo Alejandro Guigini, José Ignacio Peinado-Fabregat, Mónica Climente-Martí
10.1016/j.farma.2024.11.004
Full text access
Available online 16 December 2024
Should the funding of laxatives be reconsidered? Problems in complex chronic and palliative paediatric patients
Lucía Hernández Peláez, José Vicente Serna Berná, María de Castro Julve, Alba Pérez Contel
10.1016/j.farma.2024.11.001
Full text access
Available online 16 December 2024